Study to Evaluate ASN008 Topical Gel (TG)

Status:
Completed

Trial end date:
2020-03-20

Target enrollment:

Participant gender:

This is an ascending dose escalation study to test the safety, tolerability and preliminary efficacy of ASN008 TG in first-in-human subjects

Phase 1

Asana BioSciences